Delivery Order SPE2DB22D3009-SPE2DB25FAJ80
Award Date
11/18/24
Potential Completion Date
11/19/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.92 Firm Fixed Price Delivery Order is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S, a medication, with a period of performance through May 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S, a pharmaceutical product. The contract has a firm fixed price pricing structure and a ceiling value of $7,142.05. The period of performance runs through May 20, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,559.32 firm fixed-price delivery order (SPE2DB22D3004|SPE2DB25FPS06) is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S to support military healthcare programs. The contract has an ultimate completion date of February 27, 2025 and was awarded on February 26, 2025. It is not designated as a set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of PRILOSEC DR 10 MG SUSPENSION 30S. The $2,032.38 firm fixed-price delivery order contract has an ultimate completion date of October 30, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $3,316.27, is for the delivery of 4564339546 PRILOSEC DR 10 MG SUSPENSION 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order without a set-aside designation. Amerisourcebergen holds a much larger Indefinite...
The federal contract award SPE2DB22D3004|SPE2DB25FNS43 was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,103.48 firm fixed-price delivery order is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S, a prescription medication. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds two Indefinite Delivery Contracts (IDCs) with the DLA and...
This federal contract award is for the delivery of Prilosec DR 10 mg suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $12,609.47 and an ultimate completion date of August 8, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support...
This federal contract award, valued at $1,386.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prilosec DR 10 mg suspension, a prescription medication. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRYE3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $25,395.84 firm-fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension in 30-count packages. The contract has an ultimate completion date of September 20, 2023. The award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567908468 - Prilosec DR 10 MG Suspension 30S, a pharmaceutical product. The contract has a ceiling value of $4,039.89 and runs through April 15, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a...